FDA, Trump and Marty Makary

Johns Hopkins’ Marty Makary, Trump’s choice for FDA, a ‘brilliant surgeon’ with some ‘worrisome’ views
Maryland scholars on Monday alternately described President-elect Donald Trump’s pick to lead the U.S. Food and Drug Administration — Dr. Marty Makary, a Johns Hopkins researcher, surgeon and author — as a “courageous leader” and a “reasonable choice,” who nevertheless espouses some “worrisome” views.
Hims & Hers jumps after Trump nominates Dr. Marty Makary for FDA
Shares of Hims & Hers are moving higher after President-elect Donald Trump nominated Dr. Marty Makary, a pancreatic surgeon at Johns
Who is Dr. Marty Makary, Trump’s pick to head the FDA?
The nominee, a surgeon at Johns Hopkins, has criticized the use of pesticides on food and the industry turning against “natural fat.”
Trump picks Dr. Marty Makary as Food and Drug Administration commissioner
President-elect Trump announced on Friday that he is nominating Dr. Marty Makary, a Johns Hopkins School of Medicine professor, to head the Food and Drug Administration.
Hims & Hers Shares Jump as Trump FDA Pick Seen as Major Ally
Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the company is poised to be a major beneficiary of President-elect Donald Trump’s nomination of Marty Makary to lead the Food and Drug Administration.
Healthy Returns: Trump's FDA pick Makary may be a relief for biotech and pharma, analysts say
Trump’s FDA pick, Marty Makary, appears to be quelling fears about a major disruption to biotech and pharma. Neuralink approved for new studies, company says.
Trump choices Marty Makary, Jay Bhattacharya will disrupt our health agencies to save lives
The public-health establishment and left-wing media are rushing to discredit President-elect Donald Trump’s picks to lead ...
Hunterbrook goes long Hims & Hers after short position in June
After going short the stock in June based on Hunterbrook Media’s reporting, Hunterbrook Capital said today it is long Hims & Hers Health.
What's Going On With Hims & Hers Health Stock Monday?
Shares of Hims & Hers Health, Inc. (NYSE: HIMS) traded higher on Monday in response to President-elect Donald Trump's plans ...
Hims & Hers surges: Analysts say it's well-positioned under Trump
Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald ...
Modern Healthcare4d
Hims & Hers shares jump as Trump’s FDA pick seen as major ally
Hims & Hers Health Inc. shares surged as much ... major beneficiary of President-elect Donald Trump’s nomination of Marty Makary to lead the Food and Drug Administration. Hunterbrook said ...
Trump Picks Vaccine Mandate Critic Dr. Jay Bhattacharya to Head National Institutes of Health
President-elect Donald Trump has tapped Dr. Jay Bhattacharya, a Stanford health economist and critic of pandemic lockdowns and vaccine mandates, to lead the nation's largest medical research agency, ...